Proteomic analysis of supernatants of stored red blood cell products

Transfusion

Volumn 45, Issue 9, 2005, Pages 1426-1433

  Anniss, Angela M ^a   Glenister, Kristen M ^a   Killian, Jessica J ^a   Sparrow, Rosemary L ^a  

^a AUSTRALIAN RED CROSS BLOOD SERVICE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PHASE PROTEIN; PLASMA PROTEIN; REGULATOR PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; BLOOD BANK; BLOOD FILTRATION; BLOOD TRANSFUSION; CELL ADHESION; ERYTHROCYTE PRESERVATION; GEL ELECTROPHORESIS; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; LEUKAPHERESIS; MASS SPECTROMETRY; NORMAL HUMAN; PROTEIN ANALYSIS; PROTEOMICS; REGULATORY MECHANISM; BLOOD ANALYSIS; BLOOD COMPONENT THERAPY; BLOOD STORAGE; METHODOLOGY; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ACUTE-PHASE PROTEINS; BLOOD BANKS; BLOOD CHEMICAL ANALYSIS; BLOOD COMPONENT TRANSFUSION; BLOOD PRESERVATION; BLOOD PROTEINS; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; HUMANS; MASS SPECTROMETRY; PROTEOMICS;

EID: 26944439128     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2005.00547.x     Document Type: Article

References (27)

1. Hogman CF, Meryman HT. Storage parameters affecting red blood cell survival and function after transfusion. Transfus Med Rev 1999;13:275-96.
2. Tinmouth A, Chin-Yee I. The clinical consequences of the red cell storage lesion. Transfus Med Rev 2001;15:91-107.
3. Bordin JO, Heddle NM, Blajchman MA. Biologic effects of leukocytes present in transfused cellular blood products. Blood 1994;84:1703-21.
4. Kao KJ. Mechanisms and new approaches for the allogeneic blood transfusion-induced immunomodulatory effects. Transfus Med Rev 2000;14:12-22.
5. Fey SJ, Larsen PM. 2D or not 2D: two-dimensional gel electrophoresis. Curr Opin Chem Biol 2001;5:26-33.
6. Ong SE, Pandey A. An evaluation of the use of two-dimensional gel electrophoresis in proteomics. Biomol Eng 2001;18:195-205.
7. Anderson NL, Polanski M, Pieper R, et al. The human plasma proteome: a nonredundant list developed by combination of four separate sources. Mol Cell Proteomics 2004;3:311-26.
8. Omenn GS. The Human Proteome Organization Plasma Proteome Project pilot phase: reference specimens, technology platform comparisons, and standardized data submissions and analyses. Proteomics 2004;4:1235-40.
9. O'Neill EE, Brock CJ, von Kriegsheim AF, et al. Towards complete analysis of the platelet proteome. Proteomics 2002;2:288-305.
10. Garcia A, Prabhakar S, Brock CJ, et al. Extensive analysis of the human platelet proteome by two-dimensional gel electrophoresis and mass spectrometry. Proteomics 2004;4:656-68.
11. Piubelli C, Galvani M, Hamdan M, et al. Proteome analysis of rat polymorphonuclear leukocytes: a two-dimensional electrophoresis/mass spectrometry approach. Electrophoresis 2002;23:298-310.
12. Vuadens F, Gasparini D, Deon C, et al. Identification of specific proteins in different lymphocyte populations by proteomic tools. Proteomics 2002;2:105-11.
13. Kakhniashvili DG, Bulla LA Jr, Goodman SR. The human erythrocyte proteome: analysis by ion trap mass spectrometry. Mol Cell Proteomics 2004;3:501-9.
14. Snyder EL, Dunn BE, Giometti CS, et al. Protein changes occurring during storage of platelet concentrates: a two-dimensional gel electrophoretic analysis. Transfusion 1987;27:335-41.
15. Aminoff D, Rolfes-Curl A, Supina E. Molecular biomarkers of aging: the red cell as a model. Arch Gerontol Geriatr Supplement 1992;3:7-16.
16. Sparrow RL, Patton KA. Supernatant from stored red blood cell primes inflammatory cells: influence of prestorage white cell reduction. Transfusion 2004;44:722-30.
17. Humbert JR, Fermin CD, Winsor EL. Early damage to granulocytes during storage. Semin Hematol 1991;28:10-3.
18. Frabetti F, Tazzari PL, Musiani D, et al. White cell apoptosis in platelet concentrates. Transfusion 2000;40:160-8.
19. Hess JR, Greenwalt TG. Storage of red blood cells: new approaches. Transfus Med Rev 2002;16:283-95.
20. Schenk BI, Petersen F, Flad HD, et al. Platelet-derived chemokines CXC chemokine ligand (CXCL) 7, connective tissue-activating peptide III, and CXCL4 differentially affect and cross-regulate neutrophil adhesion and transendothelial migration. J Immunol 2002;169:2602-10.
21. Bickerstaff MC, Botto M, Hutchinson WL, et al. Serum amyloid P component controls chromatin degradation and prevents antinuclear autoimmunity. Nat Med 1999;5:694-7.
22. Noursadeghi M, Bickerstaff MC, Gallimore JR. Role of serum amyloid P component in bacterial infection: protection of the host or protection of the pathogen. Proc Natl Acad Sci U S A 2000;97:14584-9.
23. Beydemir S, Ciftci M, Kufrevioglu OI, et al. Effects of gentamicin sulfate on enzyme activities of carbonic anhydrase from human erythrocytes in vitro and from rat erythrocytes in vivo. Biol Pharm Bull 2002;25:966-9.
24. Kumuda CD, White CW. Redox systems of the cell: possible links and implications. Proc Natl Acad Sci U S A 2002;99:9617-8.
25. Kang SW, Chae HZ, Seo MS, et al. Mammalian peroxiredoxin isoforms can reduce hydrogen peroxide generated in response to growth factors and tumor necrosis factor-α. J Biol Chem 1998;273:6297-302.
26. van Gent D, Sharp P, Morgan K, et al. Serpins: structure, function and molecular evolution. Int J Biochem Cell Biol 2003;35:1536-47.
27. Beaudeux JL, Leger P, Dequen L, et al. Influence of hemolysis on the measurement of S-100beta protein and neuron-specific enolase plasma concentrations during coronary artery bypass grafting. Clin Chem 2000;46:989-90.